Immune Landscape and Application of Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma
Yanhe An, Na Luo · 2025
Read Immune Landscape and Application of Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma by Yanhe An, Na Luo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732499.txt.
Description
Yanhe An and Na Luo review immune-based treatment for the most common type of kidney cancer. This clear cell type makes up most kidney cancers, and drugs that block blood vessel growth already changed its care. Newer drugs that release immune brakes also work, as their 2025 review explains.
The review walks through the disease's tissue, gene, and immune traits in depth. It then weighs trial results for vessel drugs and immune drugs, alone and in mixes with older or newer partners. A pressing gap runs through the field: no firm markers yet predict who will respond. The pair aim to give clinicians a base for picking strategies while that hunt goes on.
Catalog record
| CREATOR | Yanhe An, Na Luo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |